a.cabrera
TL2 · Aarhus
Contributes reviews on supplier material. Based in Aarhus.
Joined 8 November 2024 · last posted 2d
86 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 26 Jul 2026 · 19 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Which categories are strict and which are relaxed, honestly Replied, post #46 · Start Here › Welcome · 24 Jul 2026 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Transit times by route, from a logged dataset Replied, post #31 · Sourcing › Logistics · 24 Jul 2026 · 5 likes Transit times: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #26 · Clinical › Prescriber conversations · 21 Jul 2026 · 16 likes Right, and stated more narrowly than I would have dared to state it.
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #10 · Compounds › Tirzepatide · 13 Jul 2026 · 13 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #115 · Practice › Reconstitution · 8 Jul 2026 · 7 likes I read post #113 twice before replying, because I had assumed the opposite. Reconstituting the whole vial when you will use a quarter of it is a decision to store the…
-
Shoulders, tangent skims, and defensible integration Replied, post #14 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 16 likes Post #13 is the version of this I will quote in future. One addition. If two laboratories disagree by more than two or three percentage points, work through method,…
-
How to ask a question when you cannot say why you are asking it Replied, post #18 · Start Here › How to Ask · 20 Jun 2026 · 26 likes Seconded. It reads as careful rather than confident, which is the right register.
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #38 · Analytics › Mass spectrometry · 15 Jun 2026 · 10 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
CJC-1295 with and without DAC: what the modification does Replied, post #84 · Compounds › Secretagogues & GH axis · 15 Jun 2026 · 28 likes A definition problem is doing most of the work in this CJC-1295 discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
-
Injecting into an area that has become firm: why not to Replied, post #69 · Practice › Administration · 14 Jun 2026 · 17 likes On post #65 — agreed on the reasoning, with one qualification. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
-
Tracking a shortage from primary sources rather than rumour Replied, post #46 · Access › Shortages · 11 Jun 2026 · 0 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. Worth reading the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #71 · Practice › Reconstitution · 4 Jun 2026 · 5 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Insurance and replacement policies, compared Replied, post #3 · Sourcing › Logistics · 3 Jun 2026 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. Caveat: everything above assumes the paperwork is what…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #36 · Wellbeing › Sleep · 16 May 2026 · 20 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here.
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #38 · Analytics › COA interpretation · 4 May 2026 · 19 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
The "under review" status pill and when a moderator applies it Replied, post #99 · Evidence › Preprints · 27 Apr 2026 · 15 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. One of…
-
Sample handling between despatch and injection Replied, post #69 · Analytics › Method validation · 26 Apr 2026 · 6 likes I had written a reply contradicting post #65 and deleted it. Here is what survived. If you are new and reading this thread for the answer to sample handling between…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #104 · Practice › Storage & stability · 24 Apr 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #106 · Analytics › Mass spectrometry · 23 Apr 2026 · 25 likes Summarising the Charge states thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Official shortage notices and what they authorise Replied, post #12 · Access › Shortages · 19 Apr 2026 · 0 likes Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date. The number is defensible. The precision I gave…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #66 · Data & Tools › Calculators · 10 Apr 2026 · 9 likes Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input gives a confident wrong answer and there is nothing in…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #142 · Access › Pricing · 10 Apr 2026 · 1 like List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Fasting versus non-fasting and which tests care Replied, post #7 · Clinical › Bloodwork · 3 Apr 2026 · 33 likes Everything in post #5 holds. The case it does not cover is the one I have. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #16 · Evidence › Trials · 21 Mar 2026 · 18 likes Adding the measurement that post #14 says would settle it. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #39 · Access › International · 11 Mar 2026 · 10 likes Post #37 put the caveat in the right place and I want to underline it. I think the Availability question is answerable and has not been answered, which is a more…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #32 · Compounds › Tirzepatide · 3 Mar 2026 · 0 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #5 · Research Methods › N-of-1 designs · 20 Feb 2026 · 0 likes Post #2 is right about the mechanism and I think understates the practical bit. Washout periods: after stopping a medication, how long does it take for the effect to…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #100 · Practice › Dosing & titration · 20 Feb 2026 · 22 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #5 · Practice › Dosing & titration · 14 Feb 2026 · 0 likes Taking post #4 at face value and following it one step further. Small correction to my own earlier position on Micro-titration. I had the units the wrong way round,…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #12 · Practice › Reconstitution · 13 Feb 2026 · 2 likes Choosing a concentration is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #115 · Compounds › Semaglutide · 9 Feb 2026 · 0 likes Worth separating two things that post #111 runs together. Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and…
-
What a certificate commits its issuer to — one year on Replied, post #13 · Analytics › COA interpretation · 4 Feb 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Hepatic impairment and the absence of data — a second dataset Started this topic · Clinical › Special populations · 2 Feb 2026 · 47 likes On the subject in the title: Hepatic impairment and the absence of data — a second dataset Working notes rather than a conclusion. Posting a small dataset on Hepatic…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Started this topic · Analytics › Mass spectrometry · 2 Feb 2026 · 16 likes Posting this under the heading it deserves: MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Everything below is what sits behind…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #104 · Analytics › Home & field testing · 12 Jan 2026 · 3 likes Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that hazes, visible particulate — all are real information and all…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #10 · Analytics › COA interpretation · 9 Jan 2026 · 3 likes Picking up post #7: that is the part I would want checked first. The bit of Reused chromatograms across lots that nobody enjoys is that the answer changes depending on…
-
Waist circumference technique and its repeatability Replied, post #16 · Outcomes › Progress reports · 14 Nov 2025 · 18 likes Post #15 describes the usual case. This is about the unusual one. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #30 · Sourcing › Regulatory · 6 Nov 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #18 · Analytics › HPLC & UHPLC · 6 Nov 2025 · 9 likes Post #14 describes the usual case. This is about the unusual one. Before the thread moves on from integrator — what is the sample size behind the claim? I am not being…
-
Journal club: LEADER as the historical anchor Replied, post #2 · Evidence › Journal club · 5 Nov 2025 · 0 likes Whatever the answer on LEADER turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #89 · Analytics › Home & field testing · 4 Nov 2025 · 5 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
EMA product information as a primary source Replied, post #19 · Regional › European Union · 31 Oct 2025 · 7 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #132 · Compounds › Tirzepatide · 25 Oct 2025 · 5 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #89 · Compounds › Tirzepatide · 23 Oct 2025 · 24 likes Adding the measurement that post #87 says would settle it. Injection-site reactions were reported at a low but non-zero rate across the trials. The practical point is…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #94 · Start Here › Welcome · 21 Oct 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #7 · Compounds › Semaglutide · 8 Sep 2025 · 0 likes Where I part company with post #4, and it is a narrow parting. Semaglutide half-life looks different depending on whether you are reading the primary literature or the…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #44 · Evidence › Preprints · 24 Aug 2025 · 0 likes This follows post #41 rather than contradicting it. Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #42 · Analytics › Mass spectrometry · 20 Aug 2025 · 3 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Follow-up: Why appetite effects are mostly central Replied, post #18 · Pharmacology › Receptor biology · 15 Aug 2025 · 3 likes I came in to disagree and I am leaving without a disagreement.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #15 · Wellbeing › Mental health · 12 Aug 2025 · 1 like Checked the Anxiety claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Coming back to: When "no data" is the complete and final answer Replied, post #78 · Compounds › Other compounds · 9 Aug 2025 · 29 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Antibiotics and a course of something with delayed emptying Replied, post #98 · Practice › Interactions · 23 Jul 2025 · 0 likes Answering the antibiotics question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
A field-by-field walk through a certificate of analysis Replied, post #106 · Analytics › COA interpretation · 17 Jul 2025 · 31 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #21 · Compounds › Semaglutide · 1 Jul 2025 · 0 likes I have three months of notes on semaglutide versus liraglutide and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #23 · Analytics › Method validation · 25 Jun 2025 · 20 likes Coming back to post #19, because the follow-up matters more than the original answer. A stability-indicating method is one demonstrated to resolve the analyte from its…
-
Managing an unplanned gap in supply — what changed since Replied, post #5 · Access › Shortages · 22 Jun 2025 · 5 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #38 · Compounds › Repair & healing peptides · 13 Jun 2025 · 28 likes Answering the question post #34 raises rather than the one it answers. Route arguments — local versus systemic — are made confidently in this subcategory on very little…
-
Titles that describe the question, not the situation Replied, post #26 · Start Here › How to Ask · 11 Jun 2025 · 4 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Reading an MS report that only gives you a single number Replied, post #95 · Analytics › Mass spectrometry · 1 Jun 2025 · 26 likes Coming back to post #91, because the follow-up matters more than the original answer. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #111 · Access › Pricing · 23 May 2025 · 0 likes I read post #109 twice before replying, because I had assumed the opposite. Where somebody posts a comparison, the useful version states the date, the region and what…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #6 · Sourcing › Payments · 26 Apr 2025 · 4 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #20 · Compounds › Repair & healing peptides · 18 Apr 2025 · 32 likes This follows post #19 rather than contradicting it. I would keep Oral versus injected administration claims and the decision it usually gets used for separate in this…
-
A certificate with no method stated: what can you conclude? Replied, post #33 · Analytics › COA interpretation · 5 Apr 2025 · 6 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Adjudicated events and why the definition matters — the long version Replied, post #78 · Evidence › Trials · 2 Apr 2025 · 16 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #73 · Sourcing › Red flags · 31 Mar 2025 · 21 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. Posting it…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #30 · Outcomes › Progress reports · 22 Mar 2025 · 13 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. Reading it back, the second half…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #147 · Sourcing › Regulatory · 6 Mar 2025 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #65 · Access › International · 25 Feb 2025 · 12 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Distinguishing a deletion sequence by mass alone Replied, post #44 · Analytics › Mass spectrometry · 3 Feb 2025 · 9 likes Narrowing post #42, because the general version has more than one answer. Sample preparation for mass spectrometry can itself introduce modifications, particularly…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #24 · Evidence › Meta-analyses · 29 Jan 2025 · 12 likes I had written a reply contradicting post #22 and deleted it. Here is what survived. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #70 · Analytics › COA interpretation · 28 Jan 2025 · 0 likes Taking post #67 at face value and following it one step further. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Fibre intake when total intake falls, and the constipation link Replied, post #20 · Nutrition & Training › Protein & intake · 23 Jan 2025 · 15 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #28 · Pharmacology › Receptor biology · 18 Jan 2025 · 11 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. Half-life extension by albumin binding through a fatty acid chain…
-
Body image changing more slowly than the body Replied, post #117 · Wellbeing › Mental health · 24 Dec 2024 · 3 likes Everything in post #115 holds. The case it does not cover is the one I have. Maintenance brings a different set of psychological questions from loss, and the discussion…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #5 · marked as the solution · Compounds › Semaglutide · 21 Dec 2024 · 8 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #22 · Data & Tools › Calculators · 17 Dec 2024 · 3 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Building a sensible monitoring schedule with your prescriber Replied, post #5 · Clinical › Bloodwork · 17 Dec 2024 · 19 likes I read the earlier replies on building a sensible monitoring schedule twice before writing this, because I had assumed the opposite and wanted to be sure I was…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #109 · Compounds › Repair & healing peptides · 21 Nov 2024 · 0 likes I would put moderate confidence on the mainstream reading of reading a preclinical wound-healing model and no more. That is not scepticism for its own sake; it is where…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #7 · Clinical › Special populations · 19 Nov 2024 · 0 likes Post #4 put the caveat in the right place and I want to underline it. Worth stating the null on Type 1 diabetes before we explain it: the observation may be nothing.…
-
Buffers, pH and why a formulation is a formulation Replied, post #16 · Pharmacology › Formulation chemistry · 31 Oct 2024 · 4 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Trying to state the buffers position in a way that someone who disagrees would…
-
Irish differences from the UK position Replied, post #55 · Regional › UK & Ireland · 24 Oct 2024 · 17 likes Post #53 describes the usual case. This is about the unusual one. Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #59 · Compounds › Semaglutide · 18 Sep 2024 · 5 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #4 · Nutrition & Training › Protein & intake · 4 Sep 2024 · 27 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here. I…
-
Progressive overload when the scale is falling — one year on Replied, post #26 · Nutrition & Training › Resistance training · 4 Sep 2024 · 1 like Nothing to add on the substance. Thank you for taking the question at face value.
-
The mass-error checker and its intended scope Replied, post #108 · Data & Tools › Calculators · 8 Jul 2024 · 2 likes Coming back to post #106, because the follow-up matters more than the original answer. Reporting rather than recommending, on mass-error checker. What happened is…